✦ LIBER ✦

A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients

✍ Scribed by E. DeJesus; A. Mills; L. Bhatti; C. Conner; S. Storfer

Book ID: 111309731
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 266 KB
Volume: 65
Category: Article
ISSN: 1368-5031
DOI: 10.1111/j.1742-1241.2011.02807.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipid profiles for nevirapine vs. atazan

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)

✍ D Podzamczer; J Andrade-Villanueva; B Clotet; S Taylor; JK Rockstroh; P Reiss; P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Comparison of Body Composition Changes B

Comparison of Body Composition Changes Between Atazanavir/Ritonavir and Lopinavir/Ritonavir Each in Combination with Tenofovir/Emtricitabine in Antiretroviral-Naïve Patients with HIV-1 Infection

✍ Moyle, Graeme J.; Hardy, Hélène; Farajallah, Awny; DeGrosky, Michelle; McGrath, 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 371 KB

Randomized comparison of metabolic and r

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients

✍ SME Vrouenraets; FWNM Wit; E Fernandez Garcia; GJ Moyle; AG Jackson; C Allavena; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Safety and efficacy of Tenofovir/Emtrici

Safety and efficacy of Tenofovir/Emtricitabine or Abacavir/Lamivudine in combination with Efavirenz in Treatment Naïve HIV patients: A 5 year retrospective observational cohort study. (The TOKEN Study)

✍ Pammi, M.; Arumainayagam, J.; Kumari, B.; Ahmed-Jushuf, I.; Carlin, E. M; Chandr 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

PIN4 EFFICACY AND SAFETY OF THE COMBINAT

PIN4 EFFICACY AND SAFETY OF THE COMBINATION EFAVIRENZ (EFV), TENOFOVIR (TDF) AND EMTRICITABINE (FTC) ONCE A DAY IN TREATMENT OF NAïVE ADULT PATIENTS WITH HIV-1 INFECTION: A SYSTEMATIC REVIEW

✍ A. Rizzoli-Cordoba; I. Delgado-Ginebra 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Once-daily atazanavir/ritonavir versus t

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

✍ Jean-Michel Molina; Jaime Andrade-Villanueva; Juan Echevarria; Ploenchan Chetcho 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 246 KB